市场立即捐赠成为会员

购物车 (0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

Millennium Chelsea Harbour Hotel

2017 年 05 月 10 日 9:00 上午 - 2017 年 05 月 11 日 5:30 下午

Chelsea Harbour, London, SW10 0XG, United Kingdom

Pharmacovigilance Conference

Pharmacovigilance Update: Practical Approaches to Current Challenges - Interactive Session and Workshop Series

返回 Agenda

Session 6: Pharmacoepidemiological Studies for Pharmacovigilance Plan

Session Chair(s)

Katherine Donegan

Katherine Donegan

Head of Epidemiology

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Steve Hobbiger

Senior Vice President and QPPV, R&D

GlaxoSmithKline , United Kingdom

Studies proposed in a pharmacovigilance plan aim to characterise the main adverse drug reactions (ADRs) to be followed in the life cycle of medicinal products. With some examples, pros and cons of the methods to be used in pharmacovigilance plans will be presented.

Speaker(s)

Marianne Cunnington

GlaxoSmithKline, United Kingdom

Julia Stowe

Julia Stowe

Public Health England, United Kingdom

Researcher